WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 3 fonti

What's Going on With Takeda Pharmaceutical Stock Thursday? - Takeda Pharmaceutical Co (NYSE:TAK)

Takeda and Insilico Medicine launch a strategic AI drug discovery collaboration to identify next-generation therapies.

Raccontata dacryptobriefing.commorningstar.combenzinga.com

Confronto fonti

3 prospettive sulla stessa storia
AI · summaries
benzinga.comStai leggendo8 g fa

What's Going on With Takeda Pharmaceutical Stock Thursday? - Takeda Pharmaceutical Co (NYSE:TAK)

Takeda and Insilico Medicine launch a strategic AI drug discovery collaboration to identify next-generation therapies.

originale
morningstar.com9 g fa

Insilico Medicine Announces Collaboration with Takeda to Advance Strategic AI Drug Discovery

Insilico Medicine Announces Collaboration with Takeda to Advance Strategic AI Drug Discovery

Leggi questa versione → originale

Timeline cronologica

  1. giovedì 2 luglio 2026·cryptobriefing.com

    Takeda and Insilico ink $600M AI drug discovery agreement

    Takeda and Insilico Medicine sign a $600M AI drug discovery deal, adding to Insilico's growing portfolio of billion-dollar pharma partnerships in 2026.

  2. giovedì 2 luglio 2026·morningstar.com

    Insilico Medicine Announces Collaboration with Takeda to Advance Strategic AI Drug Discovery

    Insilico Medicine Announces Collaboration with Takeda to Advance Strategic AI Drug Discovery

cryptobriefing.com9 g fa

Takeda and Insilico ink $600M AI drug discovery agreement

Takeda and Insilico Medicine sign a $600M AI drug discovery deal, adding to Insilico's growing portfolio of billion-dollar pharma partnerships in 2026.

Leggi questa versione → originale
  • giovedì 2 luglio 2026·benzinga.com

    What's Going on With Takeda Pharmaceutical Stock Thursday? - Takeda Pharmaceutical Co (NYSE:TAK)

    Takeda and Insilico Medicine launch a strategic AI drug discovery collaboration to identify next-generation therapies.